Inhibition of immune activation by a novel nuclear factor-kappa B inhibitor in HTLV-I-associated neurologic disease. [electronic resource]
Producer: 20110606Description: 3363-9 p. digitalISSN:- 1528-0020
- Benzamides -- pharmacology
- Cell Proliferation -- drug effects
- Cells, Cultured
- Cyclohexanones -- pharmacology
- Drug Evaluation, Preclinical
- HeLa Cells
- Human T-lymphotropic virus 1 -- drug effects
- Humans
- Immunologic Factors -- pharmacology
- Immunotherapy -- methods
- Leukocytes, Mononuclear -- immunology
- Lymphocyte Activation -- drug effects
- NF-kappa B -- antagonists & inhibitors
- Paraparesis, Tropical Spastic -- blood
- Signal Transduction -- drug effects
- Viral Load -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.